The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing. Statewide respiratory illnesses are labeled as “very high,” according to the U.S.